News & Updates

Biomarker-driven therapies superior to standard care in breast cancer
Biomarker-driven therapies superior to standard care in breast cancer
02 Nov 2023

Patients with breast cancer may gain greater therapeutic advantages from biomarker-driven than standard-of-care therapies, suggests a study.

Biomarker-driven therapies superior to standard care in breast cancer
02 Nov 2023
Esketamine outperforms quetiapine in head-to-head depression trial
Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023 byJairia Dela Cruz

In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.

Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023